Web Analytics Made Easy - StatCounter

Phenoxyethanol Tenders

Get complete information related to latest Phenoxyethanol Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Phenoxyethanol Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Phenoxyethanol Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :40752423 Due date: 08 Aug, 202508 Aug, 2025 NA
Tender For bid to ras bid to ras supply of sirolimus drug eluting balloon with cell adherent micro reservoir sustained release technology with , paclitaxel drug eluting ptca balloon catheter assorted sizes , rapid exchange cutting balloon (microsurgical dilatation device) assorted sizes

CTN :40752340 Due date: 07 Aug, 202507 Aug, 2025 NA
Tender For bid to ras supply of biodegradable polymer coated cobalt chromium sirolimus drug eluting stent system with ultrathin 60 , biodegrabable polymer co cr sirolimus drug eluting stent with 65 m strut thickness assorted sizes , sirolimus elluting bio reabsorbabale (brs) of plla backbone, bio reabsorbabale polymer (pdlla) strut

CTN :40696145 Due date: 07 Aug, 202507 Aug, 2025 NA
Tender For corrigendum : cardiologyconsumable/01 - sirolimus stainless steel biodegradable polymer drug eluting stent, sirolimus cobalt chromium biodegradable polymer drug eluting stent, everolimus eluting cobalt chromium coronary stent system, sirolimus elutingcobalt chromium coronary stent system, everolimus drug eluting cobalt chromium stent, everolimus / or sirolimus eluting cobalt chromium polymer free drug eluting stent, sirolimus eluting cobalt chromium coronary stent system, sirolimus eluting cobalt chromium coronary stent system, coronary stent graft system rapid exchange rx platform, everolimus drug eluting cobalt chromium multi link 8 design stent with fluorinated copolymer, cobalt chromium everolimus eluting des, everolimus drug eluting coronary stent - platinum chromium platform, everolimus coated drug eluting coronary stent - platinum chromium, everolimus coated drug eluting coronary stent - platinum chromium, cobalt chromium sirolimus des, platinum iridium + cobalt chromium outer zotarolimus des, cobalt chromium sirolimus des, covered stent, semi compliant sc ptca balloon, semi compliant sc ptca balloon, semi compliant sc ptca balloon, non compliant nc ptca balloon, non compliant nc ptca balloon, cutting balloon, coronary scoring balloon, coronary scoring balloon, coronary scoring balloon, ultra high pressure balloon (non scoring) with specialised indeflator, coronary drug eluting balloon (paclitaxel), coronary deb (sirolimus), coronary deb (paclitaxel), coronary deb (paclitaxel), coronary deb (sirolimus)

Central Government/Public Sector

CTN :41279885 Due date: 06 Aug, 202506 Aug, 2025 NA
Tender For supply of (ph no.:23038) sirolimus 2 mg tab ]

CTN :41260669 Due date: 20 Aug, 202520 Aug, 2025 NA
Tender For supply of sirolimus coated drug eluting coronary stent

CTN :41168179 Due date: 11 Aug, 202511 Aug, 2025 NA
Tender For procurement of drugs and expendable medical stores dpp 11 - drugs and consumables, calamine 8% with 10 % light liquid paraffin, 50 ml bott, betamethasone dipropionate usp0.05mg and gentamycin sulphatetube1 mg/gm tube of 5gm, betamethasone dipropionate usp 0.05 mg and gentamycin 1 mg/gm tube of 20gm, desonide 0.05% bott of 30 ml, framycetin sulphate cream bp 1% cream 20 gms, sisomicin sulphate skin cream 0.10%tube of 7.5 gms, talc, extractum. capae, heparin sodium,allantoin gel 20 gm tube, betamethasone 0.1% + salicylic acid 3%cream 20 gm tube, 0.55% w/w ortho-phthalaldehyde (1,2-benzene dicarboxaldehyde) solution, 1% w/v available iodine in non oxynoilodine surfactant base 500 ml bott, 10% povidone iodine solution, u.s.p equivalent to 1% available iodine 500 ml, alcohol free 2% saturated chlohexidine gluconate clothin a non-alkaline base 15- 20 cm x 15-20 cm size, ortho-phthalaldehyde 0.55% w/v with 15 test strips with each can of 5 ltr, paraformaldehyde tab, l-ornithine l asparate 5gm, 10ml inj, human albumin 20% in bott of 100ml, somatostatin inj 3mg, octreotide 0.1mg /ml inj, mesalamine suppository 500 mg, lactic acid bacillus sachet, metoclopramide syrup 5mg/5ml bott of 30ml, 5- amino salicylic acid enema 4g, hydrocortisone enema 10% w/w, methylergometrine maleate 0.2mg, 1 mlinj, linagliptin 2.5mg + metformin 1000 mg, propylthiouracil 50 mg tab, menotrophin (75u fsh+ 75 ulh) inj, testosterone propionate 25 mg inj, tab mycophenolate mofetil 750 mg, tab ferric citrate 210 mg, tab calcium acetate 435 mg plus magnesium carbonate 235 mg, ferric pyrophosphate 30 mg cap, polymyxin b immobilized extra corporealhemoperfusion cartridge for selective endotoxin removal, calcium polystryne sulfonate powdersachet of 15gm, carnitine 200 mg tab, protein supplement for predialysis renal failure, protein supplement for renal patients on hemodialysis/ capd, thermochemical disinfectant solution for haemodialysis machines containing 21g citric acid 1-hydrate; lactic acid, malic acid per 100gm of disinfectant. dispensed as solution in 5 ltr bottles, tab lanthanum carbonate 500 mg, tab lanthanum carbonate 500 mg base with hydrocortisone acetate ip 1% w/v eye & ear drops bott of 5 ml, methyl cellullose 2% solution bottle of 5 ml, carboxy methyl cellulose (cmc) 1%,gel, sodium chloride eye drops 5%, 5 ml bott, tropicamide 1% with 5% phenylephrine eye drop bott of 5 ml, tropicamide eye solution 1%, bott of 5 ml bott, beclomethasone dipropionate nasal spray 50 mcg per dose metered dose 150 units, betamethasone cream containing betamethasone valerate 0.12% with salicylic acid 3.0% cream tube of 20 gm, fluocinolone acetonide 0.01% lotion, methylphenidate 10 mg, tab, immunoglobulin (human) 500 mg inj, sumatriptan nasal spray 20mg, 10 metered doses, insulin analogue long acting basal plus long acting glp-1 analogue in pfs/pfp inj, pyrazinamide 1 gm tab, saccharomyces boullardi 250mg, co-trimoxazole (suphamethoxazole 400 mg,trimethoprim 160 mg) tab, co-trimoxazole (suphamethoxazole 100 mg,trimethoprim 20 mg) tab, isoniazid 100mg with pyridoxine 5mg tab, sulphadoxine 500 mg & pyrimethamine 25mg tab, artemether 80mg/ml, 1 ml inj, quinine dihydrochloride 300mg/ml, 2 ml inj, inj benzyl penicillin ip 10,00,000 i.u vial, codeine phosphate 15 mg tab, aspirin 25 mg, dipyridamole (er) 200 mg tab, desferrioxamine 500 mg inj, nitroglycerin 5mg controlled release patches patches, verapamil 5 mg, 2 ml inj, methyldopa tab 250mg, nebivolol 50 mg tab, antiseptic mouth wash containing sodium fluoride & triclosan bott of 100-150ml, clove oil bottle of 50ml, caffein citrate 20mg/ml inj 1ml vial, rivastigmine 9.5mg/24hrs, dry powder delivery device compatible with pv-012478, 012480, 012481,012482, potassium chloride liquid 20% bott of 200 ml, enzymatic detergent, antimicrobial hand gel containing ethyl alcohol 60% + cyclomethicone c12-15alkyl lactate + cetyl lactate +phenoxyethanol + stearyl alcohol with moisturizer, enteral feed powder, protein 85% short chain p

Central Government/Public Sector

CTN :41118637 Due date: 08 Aug, 202508 Aug, 2025 NA
Tender For srphc153055-coronary drug eluting stents with (1) stent on stainless steel or co balt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier fo r active drug ( sirolimus everolimus paclitaxel or zotarolimus shown to be effective in preve nting neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of t he stent from 12mm to 38 mm. (4) the strut thickness should be 91 micron or less. (5) stent del ivery system should be monorail (single operator exchange or rapid exchange). (6) stent shou ld be compatible with 5fr guiding catheter (7) stent design should be open cell or hybrid cell type (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in th e tender bid. (9) the long term efficacy for ten years and safety of the stent in terms of targ et vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / publishe d in peer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manu facturer/supplier should submit proof of supply of the stent to a major government institute . unit:no [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: ma x 8 lacs ]
 Loading, Please wait...

Connect us via What's Up